{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:25:46Z","timestamp":1792009546452,"version":"4.4.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1,1]]},"abstract":"<jats:p>Background. Calcific uraemic arteriolopathy (CUA, calciphylaxis) is a rare disease predominantly in dialysis patients and associated with high mortality. Painful skin ulcerations and calcification of cutaneous arterioles characterize calciphylaxis.<\/jats:p>\n               <jats:p>Methods. We established an observational, Internet-based registry allowing online notification for all German CUA cases. The registry recorded data about patient characteristics, biochemistry and therapies. Blood samples were stored in a central biobank.<\/jats:p>\n               <jats:p>Results. Between 2006 and 2015, 253 CUA patients were recorded: median age 70 [interquartile range (IQR) 61\u201376] years, 60% females and 86% (n = 207) dialysis patients, translating into an estimated annual incidence rate of 0.04% in German dialysis patients. Fifty-two per cent received vitamin K antagonists (VKAs) prior to CUA. Skin lesions were localized in 71% on the legs or gluteal region. In dialysis CUA patients median total serum calcium was 2.20 (IQR 2.06\u20132.37) mmol\/L, phosphorus 1.67 (IQR 1.35\u20132.03) mmol\/L, intact parathyroid hormone 147 (IQR 72\u2013276) pg\/mL and fetuin-A 0.21 (IQR 0.16\u20130.26) g\/L (normal range 0.35\u20130.95). Median sclerostin, osteoprotegerin, TRAP5b, bone-specific alkaline phosphatase and c-terminal FGF23 levels were all elevated. The most frequently recorded therapeutic procedures in dialysis CUA patients were as follows: wound debridement (29% of cases), stopping VKA (25%), lowering calcium supply (24%), sodium thiosulphate (22%), application of vitamin K (18%), increase of dialysis duration\/frequency (17%) and stoping active vitamin D (16%).<\/jats:p>\n               <jats:p>Conclusions. Approximately 50% of CUA patients used VKA. Our data suggest that uncontrolled hyperparathyroidism is not the key determinant of calciphylaxis. Therapeutic strategies were heterogeneous. The experience of the German registry will help substantially to initiate a large-scale multinational CUA registry.<\/jats:p>","DOI":"10.1093\/ndt\/gfv438","type":"journal-article","created":{"date-parts":[[2016,1,30]],"date-time":"2016-01-30T20:18:20Z","timestamp":1454185100000},"page":"126-132","source":"Crossref","is-referenced-by-count":84,"title":["Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry"],"prefix":"10.1093","volume":"32","author":[{"given":"Vincent M.","family":"Brandenburg","sequence":"first","affiliation":[{"name":"1Department of Cardiology, University Hospital of the RWTH Aachen, Aachen, Germany"},{"name":"2Center for Rare Diseases, University Hospital of the RWTH Aachen (ZSEA), Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Kramann","sequence":"additional","affiliation":[{"name":"2Center for Rare Diseases, University Hospital of the RWTH Aachen (ZSEA), Aachen, Germany"},{"name":"3Department of Nephrology, University Hospital of the RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansj\u00f6rg","family":"Rothe","sequence":"additional","affiliation":[{"name":"4Department of Nephrology, Klinikum Coburg, Coburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Kaesler","sequence":"additional","affiliation":[{"name":"3Department of Nephrology, University Hospital of the RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Korbiel","sequence":"additional","affiliation":[{"name":"5Clinical Trial Center-Aachen, RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Specht","sequence":"additional","affiliation":[{"name":"1Department of Cardiology, University Hospital of the RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Schmitz","sequence":"additional","affiliation":[{"name":"6Department of General, Visceral and Transplantation Surgery, University Hospital of the RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"Kr\u00fcger","sequence":"additional","affiliation":[{"name":"3Department of Nephrology, University Hospital of the RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Floege","sequence":"additional","affiliation":[{"name":"2Center for Rare Diseases, University Hospital of the RWTH Aachen (ZSEA), Aachen, Germany"},{"name":"3Department of Nephrology, University Hospital of the RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Ketteler","sequence":"additional","affiliation":[{"name":"4Department of Nephrology, Klinikum Coburg, Coburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,1,29]]},"reference":[{"key":"2025102312485660100_gfv438-B1","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s00467-013-2746-7","article-title":"Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder","volume":"29","author":"Brandenburg","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"2025102312485660100_gfv438-B2","doi-asserted-by":"crossref","first-page":"S724","DOI":"10.1007\/s11606-014-2910-1","article-title":"Quantifying a rare disease in administrative data: the example of calciphylaxis","volume":"29","author":"Nigwekar","year":"2014","journal-title":"J Gen Intern Med"},{"key":"2025102312485660100_gfv438-B3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5301\/JN.2011.6366","article-title":"Calciphylaxis: a still unmet challenge","volume":"24","author":"Brandenburg","year":"2011","journal-title":"J Nephrol"},{"key":"2025102312485660100_gfv438-B4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaad.2006.08.065","article-title":"Calciphylaxis: natural history, risk factor analysis, and outcome","volume":"56","author":"Weenig","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"2025102312485660100_gfv438-B5","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/ndt\/gfs466","article-title":"Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy","volume":"28","author":"Kramann","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312485660100_gfv438-B6","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0039-6060(97)90212-9","article-title":"Calciphylaxis in patients on hemodialysis: a prevalence study","volume":"122","author":"Angelis","year":"1997","journal-title":"Surgery"},{"key":"2025102312485660100_gfv438-B7","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2215\/CJN.00530108","article-title":"Calciphylaxis from nonuremic causes: a systematic review","volume":"3","author":"Nigwekar","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025102312485660100_gfv438-B8","first-page":"160","article-title":"Calcific uremic arteriolopathy in association with low turnover uremic bone disease","volume":"52","author":"Mawad","year":"1999","journal-title":"Clin Nephrol"},{"key":"2025102312485660100_gfv438-B9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2215\/CJN.10221014","article-title":"The effect of cinacalcet on calcific uremic arteriolopathy events in patients receiving hemodialysis: the EVOLVE trial","volume":"10","author":"Floege","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025102312485660100_gfv438-B10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.2015.156","article-title":"Sclerostin and DKK1: new players in renal bone and vascular disease","volume":"88","author":"Evenepoel","year":"2015","journal-title":"Kidney Int"},{"key":"2025102312485660100_gfv438-B11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2015.02.040","article-title":"Prevention of vasculopathy by vitamin K supplementation: can we turn fiction into fact?","volume":"240","author":"Brandenburg","year":"2015","journal-title":"Atherosclerosis"},{"key":"2025102312485660100_gfv438-B12","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/ndt\/gfr658","article-title":"A case-control study of calciphylaxis in Japanese end-stage renal disease patients","volume":"27","author":"Hayashi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312485660100_gfv438-B13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.ajkd.2015.01.034","article-title":"Calciphylaxis: risk factors, diagnosis, and treatment","volume":"66","author":"Nigwekar","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2025102312485660100_gfv438-B14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/ndt\/gfs485","article-title":"Sailing between Scylla and Charybdis: oral long-term anticoagulation in dialysis patients","volume":"28","author":"Kruger","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312485660100_gfv438-B15","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2215\/CJN.09880912","article-title":"Sodium thiosulfate therapy for calcific uremic arteriolopathy","volume":"8","author":"Nigwekar","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025102312485660100_gfv438-B16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/ckj\/sfv056","article-title":"Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet)","volume":"8","author":"Brandenburg","year":"2015","journal-title":"Clin Kidney J"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/32\/1\/126\/17109345\/gfv438.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/32\/1\/126\/17109345\/gfv438.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:49:33Z","timestamp":1761238173000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/32\/1\/126\/2931145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,29]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,29]]},"published-print":{"date-parts":[[2017,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfv438","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,1]]},"published":{"date-parts":[[2016,1,29]]}}}